Novavax Inc (NVAX)
Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)
As of Oct 21, 10:57 AM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow NVAX in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on NVAX and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
NVAX at a glance
Key statistics
$1.89B
Market capitalization
- Previous close
- $11.43
- Open
- $11.41
- Day range
- $11.02 – $11.44
- Volume
- 1.52M
- Average volume (30 sessions)
- 7.71M
- Shares outstanding
- 164.95M
- Earnings per share
- $(1.50)
- Price / sales
- 4.6
- Beta (1 year, vs SPY)
- 1.97
Where the price sits in its year
52-week range
69% of the range
- Below the 52-week high
- -16.4%
- Above the 52-week low
- +80.4%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $11.43+0.0%
- 50-day average
- $10.15+12.7%
- 200-day average
- $9.20+24.3%
Between the conventional 30 and 70 bands.
-10.8%
1 week
+9.8%
1 month
+44.5%
3 months
+70.1%
Year to date
+41.1%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with NVAX
NVAX on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on NVAX.
See the plans →
Every planScreen names like NVAX
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on NVAX
Put NVAX on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on NVAX
See whether there is an open premium alert on NVAX, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
NVAX headlines
- What's Going On With Novavax Stock On Friday?
Benzinga · May 8, 2026
- Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?
Benzinga · Mar 26, 2025
- Novavax Unusual Options Activity - Benzinga
Benzinga · Jul 19, 2024
- What the Options Market Tells Us About Novavax - Benzinga
Benzinga · Jul 11, 2024
SEC Form 4, most recent first
Insider filings
King Rachel K.
+21.3K
Director · Grant or award
· Jun 18, 2026
MCGLYNN MARGARET G
+18.9K
Director · Option exercise
· Jun 20, 2026
Shiver John W.
+21.3K
Director · Grant or award
· Jun 18, 2026
Rodgers Richard J
+21.3K
Director · Grant or award
· Jun 18, 2026
DOUGLAS RICHARD
+18.9K
Director · Option exercise
· Jun 20, 2026
Alton Gregg H
+14.2K
Director · Grant or award
· Jun 18, 2026
MOTT DAVID M
+21.3K
Director · Grant or award
· Jun 18, 2026
MOTT DAVID M
−18.9K
Director · Option exercise
· Jun 20, 2026
About Novavax Inc
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Biological Products, (no Diagnostic Substances)
- Headquarters
- Gaithersburg, MD
- Employees
- 749
- Listed since
- Dec 5, 1995
- Website
- novavax.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.